DSO Playbook:
Exit 2030.
Discover how to turn your dental group into a high-value exit-ready enterprise before 2030.
Why we made this public
We made this playbook public because we believe good thinking shouldn't be hidden behind forms or funnels. This reflects how we see the Global DSO market evolving – and the issues we believe groups need to address earlier than most do.
Who should read the DSO Playbook?
Investors AND Operators.
The DSO Playbook Exit 2030 is a practical guide for dental groups focused on scaling properly and exiting well. It explains what actually drives value, including predictable EBITDA, operational consistency, leadership depth, and clinical governance.
By treating people, compliance, and reporting as core levers, this guide helps align growth with financial results and buyer expectations.
"I read the playbook with interest, and in some parts, it really made me realize how much there is to do in our organization. I found it useful, entertaining, and – at some points – for someone in my position, truly insightful. It made me rethink some of the decisions we made, as well as rearrange some of our standing points and strategies."
The goal is simple:
Help DSOs move from expansion to real enterprise value by 2030.
The chapters.
Each chapter can be read independently — start anywhere, or read straight through.
-
Why This Playbook Matters
The dental industry is evolving fast. DSOs are expanding, regulatory demands are rising, and investors now expect more than just growth. If you run a group practice or multi-clinic DSO, you know that success can swing on small details: consistent EBITDA, operational discipline, staff retention, clinical quality, and readiness for an exit. The DSO Playbook: Exit […]
Read chapter -
Introduction
The dental industry is moving through a period of rapid consolidation. Independent practices are dealing with rising operating costs, tighter regulations, workforce shortages, and increasing pressure to modernize. At the same time, private equity firms are deploying significant capital into dental platforms because dentistry continues to show predictable demand and strong opportunities for operational improvement. This combination […]
Read chapter -
Section 1: The Clinical Case for Growth
Most DSOs focus on operational efficiency and commercial processes, yet the strongest driver of long-term value still sits in the clinical engine. Investors are clear about this now. A DSO that cannot show strong clinical quality, consistent outcomes, and a scalable treatment mix will not command a premium valuation. Clinical performance influences everything from patient […]
Read chapter -
Section 2: Implementing Change and Specialty Integration
Most DSOs reach a point where growth begins to plateau even though patient demand remains strong. A DSO that continues to operate as a collection of standalone practices cannot convert scale into real enterprise value. The group may add chairs, clinicians, and sites, but EBITDA does not move in proportion with that expansion. The turning point comes when a DSO begins […]
Read chapter -
Section 3: The Future is Now – AI, Automation & Data
The next wave of DSO growth will not be driven by adding more sites or expanding into more locations. It will be driven by how well groups use technology to unlock efficiency, scale decision-making, and raise clinical performance. A recent healthcare industry report shows that 22% of healthcare organizations have already adopted domain-specific AI tools […]
Read chapter -
Section 4: The Finance Engine
Every successful DSO eventually realizes that clinical expansion alone does not create a strong valuation. As consolidation accelerates, investors are evaluating DSOs with greater scrutiny. They are looking for stable financial controls, clear visibility of earnings, and a model that can scale without losing discipline. In fact, according to Lincoln International, there were over 120 add-on DSO acquisitions […]
Read chapter -
Section 5: Culture, Leadership & Alignment
As DSOs scale, the biggest risks rarely come from clinical output, facility expansion or investment cycles. The real pressure builds inside the organization. Clinics begin to operate at different speeds. What once relied on personal trust now depends on leadership, clarity and consistency. Culture becomes the hidden variable that determines whether operational progress converts into EBITDA growth or stalls due to fragmentation. A recent […]
Read chapter -
Section 6: Succession & Leadership Continuity
Succession is one of the quietest but most destabilizing risks inside a growing DSO. Operators usually focus on acquisitions, integrations, systems and EBITDA uplift, yet very few build a clear plan for leadership longevity. A recent survey from the National Library of Medicine found that frequent CEO turnover in healthcare leads to financial performance drop and higher risk of organizational instability [37]. […]
Read chapter -
Section 7: The Road to Exit 2030
Exiting a DSO in the next five years will require a practical understanding of how value is measured, protected and communicated. The market has shifted from growth-at-all-costs to growth with discipline. Investors and acquirers focus on the fundamentals that sustain EBITDA. They want clear evidence that the business can preserve its performance through a transition. This is why DSOs […]
Read chapter -
Section 8: Conclusion
The dental industry is entering a period of rapid transformation as DSOs scale, investors consolidate platforms, and regulatory requirements continue to evolve. By 2030, DSOs that can demonstrate predictable EBITDA, operational maturity, and strategic growth will command premium valuations. Those that fail to prepare for exit risk leaving value on the table or encountering delays that erode profitability. The key challenge for leaders is not […]
Read chapter
Ready to plan your exit?
Talk to a DSO specialist.
Get a confidential conversation about your group's exit options, valuation range, and what needs to happen before 2030 to maximise your outcome.